Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
New and Emerging Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: What is New and What is to Come.
Feasibility of Cell Therapy in Multiple Sclerosis: A Systematic Review of 83 Studies.
Discovery of Clinical Candidate GSK1842799 As a Selective S1P1 Receptor Agonist (Prodrug) for Multiple Sclerosis.
Cognitive and brain reserve for mind-body therapeutic approaches in multiple sclerosis: A review.
Reliability of Intra-Retinal Layer Thickness Estimates.
Social Cognitive Correlates of Physical Activity in African-Americans with Multiple Sclerosis.
Oct4-induced oligodendrocyte progenitor cells enhance functional recovery in spinal cord injury model.
Induction of Experimental Autoimmune Encephalomyelitis With Recombinant Human Myelin Oligodendrocyte Glycoprotein in Incomplete Freund's Adjuvant in Three Non-human Primate Species.
Diffuse cauda equina enhancement in a middle aged male with Susac syndrome and symptomatic cauda equina syndrome.
Pregnancy and perinatal outcomes among women with multiple sclerosis: A retrospective case-controlled study in South Hungary.
Mechanical energy expenditure of subject with multiple sclerosis engaged in daily activities: a case study.
Iron chelation and multiple sclerosis.
Default Network Connectivity Is Linked to Memory Status in Multiple Sclerosis.
Diffuse Granulomatous Inflammation Associated With Long-term Interferon-β Therapy.
Increased cortical curvature reflects white matter atrophy in individual patients with early multiple sclerosis.
Aquaporin 4 antibody [NMO Ab] status in patients with severe optic neuritis in India.
EP2 Receptor Signaling Regulates Microglia Death.
Aerobic Fitness Is Associated with Inhibitory Control in Persons with Multiple Sclerosis.
An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration.
Research Findings on Overactive Bladder.
THC:CBD Observational Study Data: Evolution of Resistant MS Spasticity and Associated Symptoms.
Early silent microstructural degeneration and atrophy of the thalamocortical network in multiple sclerosis.
Naturally Occurring Antibodies as Therapeutics for Neurologic Disease : Can Human Monoclonal IgMs Replace the Limited Resource IVIG?
Characteristics of flow through the internal jugular veins at cervical C2/C3 and C5/C6 levels for multiple sclerosis patients using MR phase contrast imaging.
Obesity and HLA in multiple sclerosis: Weighty matters.
Pages
« first
‹ previous
…
403
404
405
406
407
408
409
410
411
…
next ›
last »